2-(2-Acetylamino-3-phenyl-propionylamino)-5-guanidino-pentanoic acid (1-carbamoyl-2-hydroxy-ethyl)-amide

ID: ALA322972

Chembl Id: CHEMBL322972

PubChem CID: 14999608

Max Phase: Preclinical

Molecular Formula: C20H31N7O5

Molecular Weight: 449.51

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(N)=O

Standard InChI:  InChI=1S/C20H31N7O5/c1-12(29)25-15(10-13-6-3-2-4-7-13)19(32)26-14(8-5-9-24-20(22)23)18(31)27-16(11-28)17(21)30/h2-4,6-7,14-16,28H,5,8-11H2,1H3,(H2,21,30)(H,25,29)(H,26,32)(H,27,31)(H4,22,23,24)/t14-,15-,16-/m0/s1

Standard InChI Key:  HVLFXNHKZMVSAK-JYJNAYRXSA-N

Alternative Forms

  1. Parent:

Associated Targets(non-human)

Kallikrein 1 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.51Molecular Weight (Monoisotopic): 449.2387AlogP: -2.77#Rotatable Bonds: 13
Polar Surface Area: 215.02Molecular Species: BASEHBA: 6HBD: 7
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 10#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.87CX Basic pKa: 10.79CX LogP: -3.24CX LogD: -5.37
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.10Np Likeness Score: 0.38

References

1. Deshpande MS, Burton J..  (1992)  Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392.,  35  (17): [PMID:1507198] [10.1021/jm00095a002]

Source